EG24177A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
EG24177A
EG24177A EG132598A EG132598A EG24177A EG 24177 A EG24177 A EG 24177A EG 132598 A EG132598 A EG 132598A EG 132598 A EG132598 A EG 132598A EG 24177 A EG24177 A EG 24177A
Authority
EG
Egypt
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
EG132598A
Other languages
English (en)
Inventor
Valerie Berry
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26312507&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24177(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9722817.5A external-priority patent/GB9722817D0/en
Priority claimed from GBGB9813689.8A external-priority patent/GB9813689D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of EG24177A publication Critical patent/EG24177A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/36—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
EG132598A 1997-10-29 1998-10-29 Novel compounds EG24177A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722817.5A GB9722817D0 (en) 1997-10-29 1997-10-29 Novel compounds
GBGB9813689.8A GB9813689D0 (en) 1998-06-25 1998-06-25 Novel compounds

Publications (1)

Publication Number Publication Date
EG24177A true EG24177A (en) 2008-09-28

Family

ID=26312507

Family Applications (1)

Application Number Title Priority Date Filing Date
EG132598A EG24177A (en) 1997-10-29 1998-10-29 Novel compounds

Country Status (36)

Country Link
US (3) USRE39128E1 (zh)
EP (3) EP1028961B3 (zh)
JP (2) JP4227729B2 (zh)
KR (1) KR100538721B1 (zh)
CN (1) CN1205211C (zh)
AR (1) AR015987A1 (zh)
AT (2) ATE277925T1 (zh)
AU (1) AU742167C (zh)
BR (1) BR9814747B1 (zh)
CA (1) CA2307551C (zh)
CO (1) CO5021129A1 (zh)
CY (2) CY2007028I1 (zh)
CZ (1) CZ298543B6 (zh)
DE (2) DE122007000076I2 (zh)
DK (2) DK1028961T5 (zh)
DZ (1) DZ2634A1 (zh)
EG (1) EG24177A (zh)
ES (2) ES2229538T7 (zh)
FR (1) FR07C0057I2 (zh)
HK (1) HK1031376A1 (zh)
HU (2) HU229792B1 (zh)
IL (2) IL135811A0 (zh)
LU (1) LU91372I2 (zh)
MY (1) MY130665A (zh)
NL (1) NL300304I2 (zh)
NO (3) NO327392B1 (zh)
NZ (1) NZ504203A (zh)
PE (1) PE123299A1 (zh)
PL (2) PL191927B1 (zh)
PT (2) PT1930330E (zh)
SI (2) SI1930330T1 (zh)
TR (1) TR200001203T2 (zh)
TW (1) TWI232861B (zh)
UY (1) UY25225A1 (zh)
WO (1) WO1999021855A1 (zh)
ZA (1) ZA989767B (zh)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (en) * 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB9912657D0 (en) * 1999-06-01 1999-07-28 Smithkline Beecham Plc Novel compounds
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB9919839D0 (en) * 1999-08-20 1999-10-27 Smithkline Beecham Plc Novel compounds
DE60139382D1 (de) 2000-04-04 2009-09-10 Smithkline Beecham Plc 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel
GB0017073D0 (en) * 2000-07-11 2000-08-30 Univ London Microorganism
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0024811D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
GB0027705D0 (en) * 2000-11-11 2000-12-27 S P A Novel compounds
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
RU2005105576A (ru) * 2002-07-24 2005-10-10 Сандоз АГ (CH) Производные плевромутилина в качестве противомикроюных средств
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
WO2005023257A1 (en) * 2003-09-03 2005-03-17 Glaxo Group Limited Novel process, salts, compositions and use
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
GB0504314D0 (en) * 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
JP2008534444A (ja) * 2005-03-10 2008-08-28 スミスクライン・ビーチャム・コーポレイション 新規な方法
EP2298733B1 (en) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
WO2007037518A1 (ja) * 2005-09-29 2007-04-05 Dainippon Sumitomo Pharma Co., Ltd. ムチリン誘導体及びそれを含有する医薬組成物
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
WO2008096870A1 (ja) 2007-02-09 2008-08-14 Astellas Pharma Inc. アザ架橋環化合物
WO2008117796A1 (ja) * 2007-03-28 2008-10-02 Dainippon Sumitomo Pharma Co., Ltd. 新規ムチリン誘導体
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
US20090076071A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched retapamulin
WO2009070307A1 (en) * 2007-11-26 2009-06-04 Teva Pharmaceutical Industries Ltd. Amorphous retapamulin and processes for preparation thereof
US20090149655A1 (en) * 2007-12-05 2009-06-11 Lilach Hedvati Process for the preparation of Retapamulin and its intermediates
US8278313B2 (en) 2008-03-11 2012-10-02 Abbott Laboratories Macrocyclic spiro pyrimidine derivatives
US8436005B2 (en) 2008-04-03 2013-05-07 Abbott Laboratories Macrocyclic pyrimidine derivatives
WO2010056855A1 (en) * 2008-11-13 2010-05-20 Teva Pharmaceutical Industries Ltd. Preparation of retapamulin via its pleuromutilin-thiol precursor
WO2010100720A1 (ja) * 2009-03-03 2010-09-10 独立行政法人放射線医学総合研究所 コリンエステラーゼ活性測定用試薬
WO2011008572A2 (en) 2009-07-14 2011-01-20 Albany Molecular Research, Inc. 5-ht3 receptor modulators, methods of making, and use thereof
CN102344397B (zh) * 2011-08-23 2013-09-04 浙江升华拜克生物股份有限公司 一种伐奈莫林盐酸盐的提纯方法
CN103626693B (zh) * 2012-08-28 2016-09-14 中国科学院上海药物研究所 一类截短侧耳素衍生物、其药物组合物及其合成方法与用途
CN103709093B (zh) * 2012-09-28 2016-06-08 山东亨利医药科技有限责任公司 含有并环的截短侧耳素类抗生素
CN111436896A (zh) 2014-07-21 2020-07-24 恩多巧爱思股份有限公司 多焦、多相机内窥镜系统
US10874679B2 (en) 2016-03-02 2020-12-29 Bill & Melinda Gates Foundation Boron-containing small molecules
CN109195608B (zh) * 2016-03-02 2021-05-11 比尔及梅琳达盖茨基金会 含硼小分子
CN109152932B (zh) * 2016-03-02 2021-09-28 比尔及梅琳达盖茨基金会 含硼小分子
CN106496085B (zh) * 2016-09-21 2018-01-26 盐城市舜宝化工有限公司 合成盐酸沃尼妙林的中间体化合物以及盐酸沃尼妙林的制备方法
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN111574395B (zh) * 2020-06-18 2021-07-02 华南农业大学 一种具有酰胺侧链的截短侧耳素衍生物及制备与应用
AT523646B1 (de) 2020-07-21 2021-10-15 Gerd Dr Ascher Pharmazeutische Verbindungen, ihre Anwendung alleine oder in Kombination, zur Prophylaxe und lokalen Initial-Therapie bei bakteriellen und viralen Infektionen, insbesondere Coronaviren
US11155514B1 (en) * 2020-12-19 2021-10-26 Shaanxi University Of Science And Technology Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same
US11332430B1 (en) * 2021-01-25 2022-05-17 Xi'an Taikomed Pharmaceutical Technology Co., Ltd. Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same
CN112919463B (zh) * 2021-04-09 2021-10-26 南京理工大学 一种利用泰妙菌素废盐制备的活性炭及其制备方法
CN113121355B (zh) * 2021-04-13 2023-05-09 西安康诺化工有限公司 一种截短侧耳素大黄酸酯及其制备方法和应用
CN114736194A (zh) * 2022-03-29 2022-07-12 中牧实业股份有限公司 一种具有抗病原微生物活性的含吡啶季铵盐侧链的截短侧耳素衍生物及其制备方法与应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060542A (en) * 1969-07-25 1977-11-29 Biochemie Gesellschaft M.B.H. 14-Desoxy-14 thiocyanato-acetoxy-mutilin
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CH575375A5 (zh) 1972-05-25 1976-05-14 Sandoz Ag
US4208326A (en) 1971-10-05 1980-06-17 Sandoz Ltd. Pleuromutilin esters
US3919290A (en) 1972-10-03 1975-11-11 Sandoz Ltd Substituted 14-desoxy-mutilins
US4032530A (en) 1971-10-05 1977-06-28 Sandoz Ltd. Certain pleuromutilins
CH593912A5 (en) 1972-07-07 1977-12-30 Sandoz Ag Pleuromutilin derivs. - prepd. by acylating derivs. contg. a (4)-hydroxyalkyl-(1)-piperazinyl gp.
DE2404046C3 (de) 1974-01-29 1984-07-26 Henkel KGaA, 4000 Düsseldorf Verwendung von Carboxyl- bzw. Carboxylat- und Hydroxylgruppen aufweisenden Polymeren als Hautfeuchthaltemittel
US3987194A (en) 1975-05-12 1976-10-19 E. R. Squibb & Sons, Inc. Use of pleuromutilin derivatives for the treatment of swine dysentery
CH619450A5 (zh) 1976-01-15 1980-09-30 Sandoz Ag
US4130709A (en) 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
GB2025930B (en) * 1978-06-01 1983-02-09 Sandoz Ltd Process for the production of pleuromutilin derivatives
ZA80175B (en) * 1979-01-12 1981-08-26 Sandoz Ltd New pleuromutilin derivatives, their production and use
DE2966635D1 (en) * 1979-01-12 1984-03-08 Sandoz Ag New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
FR2502951B1 (fr) 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
DE3560511D1 (en) * 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT400674B (de) 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
GB9201751D0 (en) 1992-01-28 1992-03-11 Smithkline Beecham Plc Compounds
AT397654B (de) 1992-05-04 1994-06-27 Biochemie Gmbh Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
EE9700141A (et) 1994-12-23 1997-12-15 Dr. Karl Thomae Gmbh Piperasiinderivaadid, neid sisaldavad ravimid, nende kasutamine ja valmistamise meetod
BR9612426A (pt) * 1996-01-03 1999-07-13 Smithkline Beecham Plc Derivados carbomoilóxi e sua aplicação como antibacterianos
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
CA2267248A1 (en) 1996-10-01 1998-04-09 Smithkline Beecham P.L.C. Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2005023257A1 (en) 2003-09-03 2005-03-17 Glaxo Group Limited Novel process, salts, compositions and use
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph

Also Published As

Publication number Publication date
CZ298543B6 (cs) 2007-10-31
UY25225A1 (es) 2000-12-29
EP1028961B3 (en) 2008-12-03
JP2001521033A (ja) 2001-11-06
CO5021129A1 (es) 2001-03-27
BR9814747A (pt) 2001-11-20
AU742167B2 (en) 2001-12-20
AU9636198A (en) 1999-05-17
PL340254A1 (en) 2001-01-29
CA2307551A1 (en) 1999-05-06
HU229792B1 (en) 2014-07-28
CY2007028I2 (el) 2009-11-04
NO20091344L (no) 2000-06-05
KR20010031654A (ko) 2001-04-16
USRE39128E1 (en) 2006-06-13
HUP0004040A1 (hu) 2001-05-28
HK1031376A1 (en) 2001-06-15
CN1283197A (zh) 2001-02-07
CY1112062T1 (el) 2015-11-04
AR015987A1 (es) 2001-05-30
DK1028961T3 (da) 2005-01-03
NO2009023I2 (no) 2012-12-03
TWI232861B (en) 2005-05-21
AU742167C (en) 2003-08-07
EP1028961A1 (en) 2000-08-23
SI1930330T1 (sl) 2011-12-30
CA2307551C (en) 2007-01-30
NO327392B1 (no) 2009-06-22
DE69826704D1 (de) 2004-11-04
BR9814747B1 (pt) 2010-12-14
IL135811A0 (en) 2001-05-20
HUS1400060I1 (hu) 2016-09-28
DE69826704T3 (de) 2009-07-23
NO20002173D0 (no) 2000-04-27
PL191927B1 (pl) 2006-07-31
PT1028961E (pt) 2005-01-31
LU91372I2 (fr) 2007-12-24
MY130665A (en) 2007-07-31
EP1028961B1 (en) 2004-09-29
IL135811A (en) 2006-12-31
TR200001203T2 (tr) 2000-08-21
NZ504203A (en) 2002-11-26
JP4227729B2 (ja) 2009-02-18
SI1028961T1 (en) 2005-02-28
DE122007000076I2 (de) 2010-03-25
NL300304I2 (nl) 2008-03-03
ATE277925T1 (de) 2004-10-15
US6281226B1 (en) 2001-08-28
ATE525373T1 (de) 2011-10-15
DZ2634A1 (fr) 2003-03-08
ZA989767B (en) 2000-04-28
NL300304I1 (nl) 2008-01-02
NO20002173L (no) 2000-06-05
DK1930330T3 (da) 2011-12-12
PT1930330E (pt) 2011-10-31
USRE43390E1 (en) 2012-05-15
ES2371205T3 (es) 2011-12-28
KR100538721B1 (ko) 2005-12-26
FR07C0057I1 (zh) 2007-12-14
PL197672B1 (pl) 2008-04-30
CY2007028I1 (el) 2009-11-04
CN1205211C (zh) 2005-06-08
DE122007000076I1 (de) 2008-02-14
WO1999021855A1 (en) 1999-05-06
ES2229538T3 (es) 2005-04-16
EP1930330A1 (en) 2008-06-11
DK1028961T5 (da) 2009-03-09
PE123299A1 (es) 2000-02-05
LU91372I9 (zh) 2019-01-02
FR07C0057I2 (fr) 2008-05-16
HUP0004040A3 (en) 2001-08-28
ES2229538T7 (es) 2009-06-18
EP1930330B1 (en) 2011-09-21
JP2009040789A (ja) 2009-02-26
NO2009023I1 (no) 2009-10-12
DE69826704T2 (de) 2005-10-06
EP1452534A1 (en) 2004-09-01
CZ20001551A3 (cs) 2001-01-17

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
EG24177A (en) Novel compounds
GB9701684D0 (en) Novel compounds
GB9706255D0 (en) Novel compounds
GB9707830D0 (en) Novel compounds
GB9703492D0 (en) Novel compounds
GB9700901D0 (en) Novel compounds
GB9708095D0 (en) Novel compounds
GB9700687D0 (en) Novel compounds
GB9700688D0 (en) Novel compounds
GB9700689D0 (en) Novel compounds
GB9700694D0 (en) Novel compounds
GB9707829D0 (en) Novel compounds
GB9700902D0 (en) Novel compounds
GB9710248D0 (en) Novel compounds
GB9710168D0 (en) Novel compounds
GB9709521D0 (en) Novel compounds
GB9701597D0 (en) Novel compounds
GB9709520D0 (en) Novel compounds
GB9709463D0 (en) Novel compounds
GB9709094D0 (en) Novel compounds
GB9709089D0 (en) Novel compounds
GB9709085D0 (en) Novel compounds
GB9709083D0 (en) Novel compounds
GB9708492D0 (en) Novel compounds